Age-related macular degeneration 1969–2004: A 35-year personal perspective
- 31 March 2005
- journal article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 139 (3) , 405-420
- https://doi.org/10.1016/j.ajo.2004.11.050
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: Ophthalmic findingsSST report no. 13Ophthalmology, 2004
- Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomesOphthalmology, 2003
- Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1American Journal of Ophthalmology, 2003
- Laser treatment in fellow eyes with large drusen: updated findings from a pilot randomized clinical trialOphthalmology, 2003
- A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD study)Ophthalmology, 1999
- Laser treatment in eyes with large drusen: Short-term effects seen in a pilot randomized clinical trialOphthalmology, 1998
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- LASER PHOTOCOAGULATION TO TREAT MACULAR SOFT DRUSEN IN AGE-RELATED MACULAR DEGENERATIONRetina, 1994
- Risk factor analysis for atrophic and exudative age‐related macular degenerationActa Ophthalmologica, 1992
- A light microscopic and autoradiographic study of non-irradiated and irradiated ocular woundsCurrent Eye Research, 1989